Hans Desale is a doctoral student in the Department of Tropical Medicine at the Tulane University School of Public Health and Tropical Medicine, working in the Vector-Borne Infectious Diseases Research Center under Dr. Eric Dumonteil and Dr. Claudia Herrera focused on the research and control of Chagas Disease.
Research interests include one health approaches, translating laboratory research to the field, and using genetic epidemiology to better understand the transmission, ecology, pathology, diagnosis, and treatment of vector-borne diseases.
Hans received his Master of Public Health and Tropical Medicine degree from Tulane University in 2018 after completing his Bachelor in Science in biochemistry from the University of California, San Diego in 2009. Prior to graduate school, he worked in drug discovery contributing to the research team’s success of taking a molecule from the lab to an approved multiple sclerosis therapeutic. Hans has worked in a variety of public health settings worldwide, including avian flu research and endangered animal breeding/release at the San Diego Zoo, improving medical access in rural India, monitoring and evaluation research in Rwanda, modeling dengue virus transmission in Honduras, and understanding Zika virus transmission in Louisiana, USA.
Hans is an avid outdoors person, most weekends you can find him on or near water with his dog.
Investigating the mechanisms of pathogenesis from T. cruzi infection
Shelter cats host infections with multiple Trypanosoma cruzi discrete typing units in southern Louisiana. Dumonteil, E., Desale, H., Tu, W., Duhon, B., Wolfson, W., Balsamo, G., & Herrera, C. (2021). Veterinary research, 52(1), 53.
Using Prenatal Blood Samples to Evaluate COVID-19 Rapid Serologic Tests Specificity. Alger J, Cafferata ML, Alvarado T, Ciganda A, Corrales A, Desale H, Drouin A, Fusco D, Garcia J, Gibbons L, Harville E, Lopez W, Lorenzana I, Muñoz-Lara F, Palou E, Retes E, Sierra M, Stella C, Xiong X, Zambrano LI, Buekens P. Matern Child Health J. 2020 Sep;24(9):1099-1103. doi: 10.1007/s10995-020-02981-9.
Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1 ) and receptor-5 (S1P5 ) agonist with autoimmune disease-modifying activity. Scott FL, Clemons B, Brooks J, Brahmachary E, Powell R, Dedman H, Desale HG, Timony GA, Martinborough E, Rosen H, Roberts E, Boehm MF, Peach RJ. Br J Pharmacol. 2016 Jun;173(11):1778-92. doi: 10.1111/bph.13476. Epub 2016 Apr 28.
Crystal structure of a lipid G protein-coupled receptor. Hanson MA, Roth CB, Jo E, Griffith MT, Scott FL, Reinhart G, Desale H, Clemons B, Cahalan SM, Schuerer SC, Sanna MG, Han GW, Kuhn P, Rosen H, Stevens RC. Science. 2012 Feb 17;335(6070):851-5. doi: 10.1126/science.1215904. PMID: 22344443 PMID: 26990079